# XANAX XR
> **NDA021434** · New Drug Application · Sponsor: UPJOHN · Approved 2003-01-17
## Drug
- **FDA Application Number:** NDA021434
- **Application type:** New Drug Application
- **Brand name:** XANAX XR
- **Generic name:** ALPRAZOLAM
- **Active ingredients:** ALPRAZOLAM
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** UPJOHN
- **Manufacturer:** Viatris Specialty LLC
- **First approval:** 2003-01-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021434)
---
*AI Analytics · CC0 1.0*